Facing the Truth about Nanotechnology in Drug Delivery
Source abstract
Abstract
Nanotechnology in drug delivery has been manifested into nanoparticles that can have unique properties both in vitro and in vivo, especially in targeted drug delivery to tumors. Numerous nanoparticle formulations have been designed and tested to great effect in small animal models, but the translation of the small animal results to clinical success has been limited. Successful translation requires revisiting the meaning of nanotechnology in drug delivery, understanding the limitations of nanoparticles, identifying the misconceptions pervasive in the field, and facing inconvenient truths. Nanoparticle approaches can have real impact in improving drug delivery by focusing on the problems at hand, such as enhancing their drug loading capacity, affinity to target cells, and spatiotemporal control of drug release.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · 3D Printing in Biomedical Research · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Departments of Biomedical Engineering and Pharmaceutics, Purdue University, West Lafayette, Indiana 47906, United States
References (32)
Show source-provided references
1. Binnig, G.; Rohrer, H.Scanning Tunneling Microscope. USP 4,343,993, filed on September 12, 1980, 1982.
2. Binnig G. · Appl. Phys. Lett. · 1982 · 40 · 17810.1063/1.92999 ↗
3. Binnig G. · Phys. Rev. Lett. · 1986 · 56 · 93010.1103/PhysRevLett.56.930 ↗
4. The White House Office of the Press Secretary. National Nanotechnology Initiative: Leading to the Next Industrial Revolution.http://clinton4.nara.gov/WH/New/html/20000121_4.html.
5. Barenholz Y. · J. Controlled Release · 2012 · 160 · 11710.1016/j.jconrel.2012.03.020 ↗
6. Park K. · J. Controlled Release · 2013 · 166 · 31610.1016/j.jconrel.2013.02.010 ↗
7. Hoffman A. S. · J. Controlled Release · 2008 · 132 · 15310.1016/j.jconrel.2008.08.012 ↗
8. Desai, N. P.; Soon-Shiong, P.; Trieu, V.Compositions and Methods of Delivery of Pharmacological Agents. U.S. Patent 7820788, October 26, 2010.
9. Liversidge, G. G.; Liversidge, E.; Sarpotdar, P. P.Surface Modified Anticancer Nanoparticles. U.S. Patent US5399363 A, March 21, 1995.
10. Friedman T. L. · 2011
11. Bae Y. H. · J. Controlled Release · 2011 · 153 · 19810.1016/j.jconrel.2011.06.001 ↗
12. Park K. · 2013 · 68910.1007/978-1-4614-7876-8_26 ↗
13. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
14. Kwon I. K. · J. Controlled Release · 2012 · 164 · 10810.1016/j.jconrel.2012.07.010 ↗
15. Rossi J. · Eur. J. Pharm. Biopharm. · 2007 · 67 · 32910.1016/j.ejpb.2007.03.016 ↗
16. Venditto V. J. · Adv. Drug Del. Rev. · 2013 · 65 · 8010.1016/j.addr.2012.09.038 ↗
17. Kratz F. · J. Controlled Release · 2012 · 164 · 22110.1016/j.jconrel.2012.05.045 ↗
18. Gao L. · J. Controlled Release · 2012 · 160 · 41810.1016/j.jconrel.2012.03.013 ↗
19. Nkansah P. · J. Controlled Release · 2013 · 169 · 15010.1016/j.jconrel.2013.03.032 ↗
20. Yuan F. · Cancer Res. · 1994 · 54 · 3352
21. Mohammad A. K. · Mol. Pharmaceutics · 2013 · 10 · 218310.1021/mp300559v ↗
22. 10.1021/nn403184u10.1021/nn403184u ↗
23. Lu W. · J. Controlled Release · 2012 · 161 · 95910.1016/j.jconrel.2012.05.014 ↗
24. Park K. · J. Controlled Release · 2012 · 161 · 96710.1016/j.jconrel.2012.07.016 ↗
25. Denison T. A. · J. Controlled Release · 2012 · 164 · 18710.1016/j.jconrel.2012.04.014 ↗
26. Banno B. · J. Pharm. Sci. · 2010 · 99 · 229510.1002/jps.21988 ↗
27. Landon C. D. · Open Nanomed. J. · 2011 · 3 · 3810.2174/1875933501103010038 ↗
28. Celcion-Corporation. Celsion Announces Results of Phase III HEAT Study of Thermodox® in Primary Liver Cancer.http://investor.celsion.com/releasedetail.cfm?ReleaseID=737033.
29. Hashimoto M. · Mol. Pharmaceutics · 2013 · 10 · 212710.1021/mp300652m ↗
30. Han B. · 2013 · 66710.1007/978-1-4614-7876-8_25 ↗
31. Shin C. S. · Mol. Pharmaceutics · 2013 · 10 · 216710.1021/mp300595a ↗
32. Park K. · J. Controlled Release · 2012 · 161 · 15010.1016/j.jconrel.2012.05.048 ↗